The FIT Stack: CJC-1295 + Ipamorelin GH Protocol

The case for natural GH optimization

Growth hormone declines roughly 14% per decade after age 30. By 60, most adults produce less than half the GH they did at 25. This decline correlates with increased body fat, decreased lean mass, poorer sleep architecture, slower recovery, and reduced skin elasticity.

The brute-force solution is exogenous HGH (somatropin): inject the hormone directly, bypass the pituitary entirely. It works, but it comes with a list of problems. Exogenous GH creates flat, non-pulsatile plasma levels instead of the natural peaks and troughs the body evolved for. Side effects include water retention, joint pain, carpal tunnel syndrome, insulin resistance, and potential acceleration of existing malignancies. It also suppresses endogenous production through negative feedback. And it costs $500-2,000/month at therapeutic doses.

The alternative: stimulate your own pituitary to produce more GH naturally, in the pulsatile pattern your body already uses. That is what the FIT Stack does.

CJC-1295 (a GHRH analog) plus Ipamorelin (a selective GHRP) is the most widely used secretagogue combination in peptide research. The two compounds activate different receptor systems on the pituitary, producing synergistic GH release that significantly exceeds either compound alone.

The receptor-level mechanism

This is where most articles on CJC-1295 + Ipamorelin get vague. The synergy is not mysterious. It is a well-characterized pharmacological interaction between two distinct receptor systems.

CJC-1295: the GHRH receptor pathway

CJC-1295 is a modified analog of Growth Hormone Releasing Hormone (GHRH), the 44-amino-acid peptide your hypothalamus releases in pulses throughout the day. It binds to the GHRH receptor (GHRH-R) on somatotroph cells in the anterior pituitary.

When GHRH-R is activated, it triggers intracellular cAMP accumulation via Gs-protein coupling. This cAMP signal activates protein kinase A (PKA), which phosphorylates CREB transcription factors, which upregulate GH gene transcription. In simpler terms: CJC-1295 tells the pituitary to produce more GH at the gene level.

The "no-DAC" form of CJC-1295 (also called Modified GRF 1-29 or Mod-GRF) has a half-life of approximately 30 minutes. This produces a clean, defined GH pulse that mimics natural physiology. The DAC (Drug Affinity Complex) version extends the half-life to roughly 6-8 days via albumin binding, which creates sustained GH elevation rather than discrete pulses. Most researchers prefer no-DAC for its physiological pulse pattern.

CJC-1295 effectively raises the "floor" of GH output. It sets a higher baseline from which GH can be released.

Ipamorelin: the ghrelin receptor pathway

Ipamorelin is a pentapeptide that activates the Growth Hormone Secretagogue Receptor (GHS-R1a), commonly called the ghrelin receptor. This is a completely different receptor system from GHRH-R.

GHS-R1a activation triggers GH release through the phospholipase C / IP3 / calcium signaling cascade, which is distinct from the cAMP pathway that GHRH uses. The result: acute GH "spikes" layered on top of whatever baseline GHRH has established.

What makes Ipamorelin special compared to older GHRPs is its selectivity. GHRP-6, the first-generation ghrelin mimetic, activates GHS-R1a but also triggers significant appetite increase, cortisol release, and prolactin elevation. GHRP-2 is slightly better but still raises cortisol. Ipamorelin activates GHS-R1a with minimal effect on cortisol, prolactin, ACTH, or appetite (Raun et al., European Journal of Endocrinology, 1998). It is the cleanest GHRP available.

Why 1 + 1 = 3

When you activate both GHRH-R (via CJC-1295) and GHS-R1a (via Ipamorelin) simultaneously, the GH release is greater than the sum of each compound individually. This is not marketing language. It is a documented pharmacological phenomenon.

The mechanism: GHRH-R activation via cAMP primes the somatotroph cell to release GH. GHS-R1a activation via calcium signaling triggers the actual release event. When both signals arrive at the same time, the cell is both primed and triggered. The result is amplified GH output from each individual somatotroph, not just additive output from two pathways working independently.

Bowers et al. demonstrated this synergy as early as 1990, showing that combined GHRH + GHRP administration produced GH peaks 2-3x higher than either compound alone (Journal of Clinical Endocrinology & Metabolism). Teichman et al. (2006) confirmed sustained GH and IGF-1 elevation with CJC-1295 specifically.

The FIT Stack uses this synergy in a single pre-mixed vial.

Why Ipamorelin over other GHRPs

This is worth addressing directly because the GHRP category includes several compounds, and the choice matters.

Ipamorelin sacrifices a small amount of peak GH magnitude for a dramatically cleaner side effect profile. For most research applications (body composition, sleep, recovery, anti-aging), the slightly lower peak is irrelevant because the sustained, pulsatile GH elevation over weeks and months matters more than any single spike.

Hexarelin deserves a specific note: it produces the strongest GH release of any GHRP but desensitizes the receptor within 2-4 weeks. It is unsuitable for protocols longer than 2 weeks. Ipamorelin does not desensitize at standard doses, making it viable for 8-12 week cycles.

The protocol

Dosing

The FIT Stack ships as a 10 mg pre-mixed vial (CJC-1295 no-DAC + Ipamorelin at a 1:1 ratio).

Standard research protocols:

• Starting dose: 100 mcg total (50 mcg of each compound) once daily
• Standard dose: 200 mcg total (100 mcg of each) once daily
• Higher dose: 300-600 mcg total (150-300 mcg of each) once daily
• Split dosing: Some protocols use 200 mcg before bed + 200 mcg upon waking

Most researchers begin at 200 mcg total and assess response over 2-3 weeks before adjusting.

Timing: why before bed

The single most important timing detail for the FIT Stack is alignment with the natural nocturnal GH pulse.

Your body releases its largest GH pulse approximately 60-90 minutes after falling asleep, during the first cycle of slow-wave (deep) sleep. This pulse accounts for roughly 50-70% of total daily GH output. Injecting CJC-1295 + Ipamorelin 30-60 minutes before bed places the exogenous GH stimulus in synchrony with this natural peak, amplifying rather than replacing the endogenous rhythm.

Recommended timing: Inject 30-60 minutes before bed, on an empty stomach.

Some protocols add a second dose upon waking (also fasted) or 30-60 minutes pre-workout. The pre-workout timing takes advantage of the exercise-induced GH response for additional synergy.

The fasting requirement

This is non-negotiable. Insulin and GH have an inverse relationship. When blood insulin is elevated (after eating), GH release from the pituitary is suppressed by 50-70%. Eating a meal within 30 minutes of injection can blunt the entire GH response.

Rules:

• Do not eat for at least 30 minutes before injection
• Do not eat for at least 30 minutes after injection
• The pre-bed dose naturally satisfies this (most people stop eating 1-2 hours before sleep)
• For morning doses: inject immediately upon waking, wait 30 minutes before breakfast
• Avoid high-glycemic foods close to injection time; even a small insulin spike can interfere

Water, black coffee, and zero-calorie beverages are fine.

Cycle length

• Standard cycle: 8-12 weeks
• Extended cycle: Up to 16 weeks (some protocols)
• Off period: 4-8 weeks between cycles
• Desensitization risk: Low for Ipamorelin, negligible for CJC-1295 at standard doses

The longer cycle length compared to recovery peptides (BPC-157 + TB-500 typically run 4-6 weeks) reflects the different goal. GH optimization is a gradual, cumulative process. Body composition changes, sleep improvements, and recovery benefits develop over weeks, not days.

Reconstitution math

The FIT Stack ships as a 10 mg lyophilized vial.

With 2 mL bacteriostatic water:

With 1 mL bacteriostatic water:

At the standard 200 mcg daily dose, a single 10 mg vial lasts approximately 7 weeks. This means one vial covers most of a standard 8-week cycle, with a second vial needed only for the final week or for higher doses.

Use the Reconstitution Calculator to verify your specific setup, and the Half-Life Visualizer to model plasma curves for CJC-1295's ~30-minute half-life and Ipamorelin's ~2-hour half-life.

What GH optimization actually means

This section exists to set expectations. The FIT Stack is not exogenous HGH. The GH elevation is real but moderate, and the effects are correspondingly more subtle than what you would see at pharmacological HGH doses.

What research consistently shows:

• Improved sleep quality. GH and deep sleep are bidirectionally linked. More GH supports better slow-wave sleep; better slow-wave sleep supports more GH. This is often the first noticeable effect, typically within 1-2 weeks. Expect deeper sleep, more vivid dreams, and feeling more rested on waking.
• Accelerated recovery. GH is anabolic. It promotes tissue repair, collagen synthesis, and protein turnover. Recovery from training and injuries improves. This becomes apparent over 3-6 weeks.
• Body composition. GH increases lipolysis (fat breakdown) and supports lean mass retention. Over 8-12 weeks, researchers typically observe modest fat reduction (particularly visceral fat) and improved muscle tone. These are not dramatic bodybuilder-level changes; they are the kind of gradual recomposition that becomes obvious in progress photos over months.
• Skin and hair quality. GH supports collagen synthesis. Many researchers report improved skin elasticity and thickness over 6-12 weeks.
• Cognitive clarity and mood. GH receptors exist in the brain. Improved sleep architecture alone accounts for significant cognitive benefits. Some researchers report enhanced focus and mood stability, though this is harder to quantify.

What the FIT Stack will not do:

• Make you look like you are on HGH at 4-6 IU/day. The GH elevation is meaningful but not supraphysiological.
• Cause water retention, joint swelling, or carpal tunnel. Those are high-dose exogenous HGH side effects.
• Replace proper training, nutrition, and sleep. It amplifies what you are already doing.

Expected timeline

Weeks 1-2: Sleep quality changes. Deeper sleep, more vivid dreams. Possible mild water retention that resolves. Some researchers report increased appetite (minimal with Ipamorelin compared to other GHRPs, but possible).

Weeks 3-4: Recovery improvements become noticeable. Faster bounce-back from training. Minor injuries resolve more quickly. Skin may appear slightly fuller.

Weeks 5-8: Body composition changes begin to manifest. Subtle fat loss, particularly around the midsection. Muscle tone improves. Sleep quality benefits are well-established. Energy and mood often stabilize.

Weeks 9-12: Cumulative effects peak. This is where the compound interest of daily GH pulses becomes most apparent. Body composition improvements are visible. Recovery capacity is markedly improved. Skin quality changes are noticeable.

Post-cycle: GH levels return to baseline over 1-2 weeks after discontinuation. The body composition and tissue remodeling effects achieved during the cycle do not immediately reverse, but maintaining them long-term requires continued training and nutrition support (or additional cycles).

CJC-1295 + Ipamorelin vs standalone compounds

Standalone CJC-1295 (no Ipamorelin): You get the elevated GH baseline (GHRH pathway) but miss the acute pulse amplification (GHRP pathway). GH output is roughly 40-60% of what the combination produces. Still useful, but you are leaving significant synergy on the table.

Standalone Ipamorelin (no CJC-1295): You get discrete GH pulses but from an unsupported baseline. The pulses are smaller because the somatotroph cells are not primed by GHRH signaling. Again, roughly 40-60% of combined output.

MK-677 (Ibutamoren): An oral ghrelin receptor agonist with a ~24-hour half-life. Convenient (no injections), but it produces sustained rather than pulsatile GH elevation, increases appetite significantly, and raises cortisol. The GH pattern is less physiological than the CJC-1295 + Ipamorelin combination. MK-677 is a reasonable option for people who cannot or will not inject, but the FIT Stack produces a cleaner GH profile. See the MK-677 guide for a full comparison.

Sermorelin: A natural GHRH(1-29) fragment with a ~10-20 minute half-life. Functionally similar to CJC-1295 but with a shorter duration of action. CJC-1295's modified amino acid sequence extends its half-life to ~30 minutes, which produces a more sustained GH pulse. Sermorelin is the FDA-approved option (for pediatric growth hormone deficiency), which gives it a regulatory advantage but no pharmacological one. See the Sermorelin guide.

Common mistakes

1. Eating too close to injection. The most common protocol error. Even a small snack 15-20 minutes before injection can blunt GH release substantially. Treat the fasting window as non-negotiable.

2. Injecting at random times. Consistency matters. The pituitary responds best to regular stimulus. Pick a time (30-60 minutes before bed is optimal) and stick to it daily.

3. Expecting HGH-level results. The FIT Stack produces a meaningful but physiological GH increase. If your mental model is exogenous HGH at bodybuilder doses, you will be disappointed. Recalibrate expectations to "optimized natural production" and the results become impressive in context.

4. Skipping the off period. While Ipamorelin desensitization risk is low, running any secretagogue indefinitely without breaks is not well-studied. Take 4-8 weeks off between 8-12 week cycles.

5. Using CJC-1295 with DAC unintentionally. The DAC version has a completely different pharmacokinetic profile (~6-8 day half-life vs ~30 minutes). It produces sustained, non-pulsatile GH elevation, which is a different research protocol entirely. The FIT Stack uses no-DAC. If you are sourcing standalone CJC-1295, verify which form you are purchasing.

6. Combining with carb-heavy pre-bed snacks. A common bodybuilding habit (casein + carbs before bed) directly conflicts with the FIT Stack's fasting requirement. Choose one or the other.

Stacking with recovery peptides

The FIT Stack pairs naturally with the Wolverine Stack (BPC-157 + TB-500) for researchers targeting both GH optimization and tissue repair. The protocol:

• Morning: Wolverine Stack dose (fasted, or near injury site)
• Pre-bed: FIT Stack dose (fasted, abdominal subQ)

The GH pulse from the FIT Stack creates a more anabolic environment that supports the tissue repair driven by BPC-157 and TB-500. This is the combination that Enhanced Games athletes like James Magnussen have publicly disclosed using.

For researchers interested in adding skin and matrix remodeling to this protocol, the GLOW Blend replaces the Wolverine Stack with a GHK-Cu + BPC-157 + TB-500 combination.

Source and availability

The FIT Stack (10 mg pre-mixed CJC-1295 + Ipamorelin) is available from our partner Ascension Peptides with 50% off using code ENHANCED. COA-verified, US-based shipping.

• FIT Stack details
• CJC-1295 compound guide
• Ipamorelin compound guide
• Reconstitution Calculator
• Half-Life Visualizer

---

This article is for educational and informational purposes only. CJC-1295 and Ipamorelin are not approved for human use. All dosing information is derived from published research and allometric scaling. Consult a qualified healthcare professional before making any decisions about peptide research.